CRISPR: Downside Bias

293
CRISPR extended its correction over the past few weeks, although the downside momentum has eased somewhat more recently. For now, we primarily expect a sell-off below the support at $30.02. Once a low is established there, the stock should move higher again. Alternatively, the shares could post another temporary rebound first. In that case, price would briefly break above the resistance at $61.76 to establish a new corrective high (probability: 34%).

免責事項

これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。